Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Bloomberg

US Power Shortage: How Small Modular Nuclear Reactors Could Fill the Gap

US electricity demand is now expected to rise 20 to 100 percent over the next 15 years as AI data centers, chip fabs and electrification strain an aging grid. Scott Strazik and Nicole Holmes of GE Vernova and Joseph Majkut of CSIS explain why nuclear especially through small modular reactors is back on the table.

Leia mais: US Power Shortage: How Small Modular Nuclear Reactors Could Fill the Gap
Grafa
Technology

Flowserve board authorizes quarterly cash dividend of $0.21 per share

Flowserve Corporation (NYSE:FLS), a major global provider of flow control products and services for infrastructure markets, has announced that its Board of Directors has authorized a quarterly cash dividend of $0.21 per share on the company’s outstanding common stock.

Leia mais: Flowserve board authorizes quarterly cash dividend of $0.21 per share
Grafa
Health

Natera and MEDSIR collaborate on MiRaDoR Phase II study in HR+/HER2- breast cancer

Natera (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research, today announced their collaboration on the MiRaDoR (NCT05708235) study.

Leia mais: Natera and MEDSIR collaborate on MiRaDoR Phase II study in HR+/HER2- breast cancer
Grafa
Health

Acadia Pharmaceuticals receives FDA approval for DAYBUE® STIX for Rett syndrome treatment

Acadia Pharmaceuticals (NASDAQ:ACAD) announced today that the U.S. Food and Drug Administration (FDA) has approved DAYBUE® STIX (trofinetide) for oral solution, a new dye- and preservative-free powder formulation of trofinetide for the treatment of Rett syndrome in both adult and pediatric patients aged two years and older.

Leia mais: Acadia Pharmaceuticals receives FDA approval for DAYBUE® STIX for Rett syndrome treatment
Grafa
Financial

Norwood Financial receives final regulatory go-ahead for PB Bankshares acquisition

Norwood Financial Corp (NASDAQ:NWFL), the holding company for Wayne Bank, has announced that it has received the final regulatory approvals necessary to complete its acquisition of PB Bankshare and its subsidiary, Presence Bank.

This final approval follows the merger's green light from PB Bankshare shareholders on December 11, 2025.

Leia mais: Norwood Financial receives final regulatory go-ahead for PB Bankshares acquisition
Grafa
Health

Relay Therapeutics reports positive subset efficacy data for zovegalisib in combination with fulvestrant

Relay Therapeutics (NASDAQ:RLAY) presented promising subset efficacy data from its ReDiscover program at the 2025 San Antonio Breast Cancer Symposium (SABCS), showcasing the combination of zovegalisib (RLY-2608) and fulvestrant in a cohort of 52 patients with estrogen receptor-positive breast cancer.

Leia mais: Relay Therapeutics reports positive subset efficacy data for zovegalisib in combination with fulvestrant
Grafa
Health

BeyondSpring unveils positive Asian subset results from Phase 3 DUBLIN-3 trial

BeyondSpring (NASDAQ:BYSI) presented encouraging results from the Asian subset of its global Phase 3 DUBLIN-3 trial at ESMO Asia 2025, evaluating the combination of plinabulin and docetaxel versus docetaxel alone in second-line and third-line EGFR wild-type non-small cell lung cancer (NSCLC).

Leia mais: BeyondSpring unveils positive Asian subset results from Phase 3 DUBLIN-3 trial
Grafa
Technology

Applied Materials announces quarterly dividend of $0.46 per share

Applied Materials (NASDAQ:AMAT) announced a quarterly cash dividend of $0.46 per share, payable on March 12, 2026, to shareholders of record as of February 19, 2026.

This marks the eighth consecutive year of dividend increases for the company, following a 15% hike in March 2025, which raised the dividend from $0.40 to $0.46 per share.

Leia mais: Applied Materials announces quarterly dividend of $0.46 per share